NEW YORK / RankWire.AI / – U.S. equities closed slightly higher on Wednesday, buoyed by a notable drop in long-term Treasury yields. The S&P 500 gained 16.22 points, or 0.21%, reaching 7,707.98, and broke a three-day losing streak. The Dow Jones Industrial Average increased by 119.65 points, or 0.22%, ending at 53,463.05. The Nasdaq Composite added 41.38 points, or 0.16%, closing at 26,331.09. The decline in government bond yields helped the major indices recover after multiple sessions of pressure from rising borrowing costs.
The U.S. Treasury Department saw bond prices rise after announcing an increase in liquidity support buybacks for longer-term government securities. Starting September 9, the maximum purchase size will rise from $2 billion to at least $4 billion per operation. This adjustment applies to nominal coupon securities in the 10-to-20-year and 20-to-30-year maturity ranges. These enhanced volumes will be maintained through November 4. The department attributed the decision to strong demand for high-quality offers, which supported the move to expand liquidity operations in these sectors.
Following the announcement, Treasury yields declined, reversing some of the recent upward trend in long-term borrowing costs. The 10-year Treasury yield dropped to approximately 4.65%, while the 30-year yield fell to around 5.20%. On Tuesday, the 30-year yield reached 5.337%, its highest level since 2007. Since bond yields move inversely to prices, increased demand for government debt led to lower yields. This retreat alleviated some of the pressure from the recent selloff in longer-term bonds.
Healthcare Sector Boosts Market Performance
Healthcare stocks contributed to the positive momentum during Wednesday’s session, with several pharmaceutical companies reporting strong gains. Moderna shares soared 177%, while Merck rose 12.6% after announcing positive results from a Phase 3 melanoma trial. The INTerpath-001 study evaluated personalized mRNA therapy intismeran autogene combined with Keytruda following surgical removal of high-risk melanoma. The trial met its primary endpoint for recurrence-free survival and also achieved a key secondary endpoint measuring survival without distant cancer spread.
The rally within the healthcare sector helped counterbalance mixed trading elsewhere, especially in the technology space. Consumer stocks also contributed, as multiple major corporations released quarterly earnings during the session. Estée Lauder increased by more than 16% following its earnings report, bolstering the gains among consumer shares. Target and Lowe’s also moved higher after reporting their latest financial results. Smaller-cap stocks outperformed larger indexes, with the Russell 2000 gaining roughly 0.5% as the broader market regained momentum.
Indices End Three-Day Losing Streak
Wednesday’s gains marked the end of a three-session decline for the S&P 500, Dow, and Nasdaq. The recovery followed earlier declines driven by rising long-term yields earlier in the week. Despite Wednesday’s positive movement, the major indices still closed the week lower. The S&P 500 was about 1% below last Friday’s level, while the Dow had fallen approximately 0.5% for the week. The Nasdaq remained roughly 1.5% lower at week’s end.
Looking at the year-to-date performance, the broader 2026 outlook remains optimistic despite this week’s dip and recent bond market pressure. As of Wednesday’s close, the S&P 500 has gained approximately 12.6% since the start of the year. The Dow is up about 11.2%, while the Nasdaq leads with a roughly 13.3% increase, reflecting its stronger performance earlier in 2023. Wednesday’s session provided a modest recovery for Wall Street, supported by lower Treasury yields and positive healthcare sector earnings, lifting all three major U.S. stock indices.